出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/09/07 05:14:39」(JST)[Wiki en表示]
|This article needs attention from an expert in Biochemistry. Please add a reason or a talk parameter to this template to explain the issue with the article. WikiProject Biochemistry may be able to help recruit an expert. (January 2012)|
|This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (January 2012)|
Lipogenesis is the process by which acetyl-CoA is converted to fats. The former is an intermediate stage in metabolism of simple sugars, such as glucose, a source of energy of living organisms. Through lipogenesis, the energy can be efficiently stored in the form of fats. Lipogenesis encompasses the processes of fatty acid synthesis and subsequent triglyceride synthesis (when fatty acids are esterified with glycerol to form fats). The products are secreted from the liver in the form of very-low-density lipoproteins (VLDL).
Fatty acid synthesis
Fatty acids synthesis starts with acetyl-CoA and builds up by the addition of two carbon units. The synthesis occurs in the cytoplasm in contrast to the degradation (oxidation), which occurs in the mitochondria. Many of the enzymes for the fatty acid synthesis are organized into a multienzyme complex called fatty acid synthetase. The major sites of fatty acid synthesis are adipose tissue and the liver.
Control and regulation
Insulin is an indicator of the blood sugar level of the body, as its concentration increases proportionally with blood sugar levels. Thus, a large insulin level is associated with the fed state. As one might expect, therefore, it increases the rate of storage pathways, such as lipogenesis. Insulin stimulates lipogenesis in two main ways: The enzymes pyruvate dehydrogenase (PDH), which forms acetyl-CoA, and acetyl-CoA carboxylase (ACC), which forms malonyl-CoA from acetyl-CoA, are obvious control points. These are activated by insulin. So a high insulin level leads to an overall increase in the levels of malonyl-CoA, which is the substrate required for fatty acids synthesis.
|This section needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (January 2012)|
Pyruvate dehydrogenase is dephosphorylated in response to increased insulin signalling. The dephosphorylated form is more active.
As insulin binds to cellular surface transmembrane receptors that intracellularly activate the adenylate cyclase enzyme that catalyze cAMP (cyclic AMP) production from ATP. The increased intracellular cAMP, acts as a second messenger, in response to the insulin binding. cAMP activates protein kinase enzyme that in turn activates phosporylase enzyme that phosphorylates and in doing so activates a number of different intracellular enzymes such as the pyruvate dehydrogenase that dehydrates pyruvate to form AcCoa. So, an extracellular hormone, insulin, can in multistep activation (cascade) activate an enzyme in the cellular matrix.
This mechanism leads to the increased rate of catalysis of this enzyme, so increases the levels of acetyl-CoA. Increased levels of acetyl-CoA will increase the flux through not only the fat synthesis pathway but also the citric acid cycle.
Note: The above is incorrect; insulin does not activate adenylate cyclase. Epinephrine via the beta adrenergic receptor and glucagon via its receptor activate adenylate cyclase, increasing cAMP levels and PKA activity. Insulin activates cAMP phosphodiesterase, which breaks down cAMP. This leads to a decrease in cAMP levels and therefore a decrease in PKA activity. With regard to Pyruvate dehydrogenase, this enzyme is inhibited when phosphorylated. Insulin stimulates the activity of pyruvate dehydrogenase phosphatase. This enzyme removes the phosphate from pyruvate dehydrogenase, allowing for conversion of pyruvate to acetyl-CoA.
Insulin affects ACC in a similar way to PDH. It leads to its dephosphorylation which activates the enzyme. Glucagon has an antagonistic effect and increases phosphorylation, deactivation, thereby inhibiting ACC and slowing fat synthesis.
Affecting ACC affects the rate of acetyl-CoA conversion to malonyl-CoA. Increased malonyl-CoA level pushes the equilibrium over to increase production of fatty acids through biosynthesis. Long chain fatty acids are negative allosteric regulators of ACC and so when the cell has sufficient long chain fatty acids, they will eventually inhibit ACC activity and stop fatty acid synthesis.
AMP and ATP concentrations of the cell act as a measure of the ATP needs of a cell and as ATP levels get low it activates the ATP synthetase which in turn phosphorylates ACC. When ATP is depleted, there is a rise in 5'AMP. This rise activates AMP-activated protein kinase, which phosphorylates ACC, thereby inhibits fat synthesis. This is a useful way to ensure that glucose is not diverted down a storage pathway in times when energy levels are low.
ACC is also activated by citrate. This means that, when there is abundant acetyl-CoA in the cell cytoplasm for fat synthesis, it proceeds at an appropriate rate.
Note: Research now shows that glucose metabolism (exact metabolite to be determined), aside from insulin's influence on lipogenic enzyme genes, can induce the gene products for liver's pyruvate kinase, acetyl-CoA carboxylase, and fatty acid synthase. These genes are induced by the transcription factors ChREBP/Mlx via high blood glucose levels and presently unknown signaling events. Insulin induction is due to SREBP-1c, which is also involved in cholesterol metabolism.
Fatty acid esterification
Experiments were conducted to study in vivo the over-all fatty acid specificity of the mechanisms involved in chylomicron cholesterol ester and triglyceride formation during fat absorption in the rat. Mixtures containing similar amounts of two, three, or four C14-labeled fatty acids (palmitic, stearic, oleic, and linoleic acids), but with varying ratios of unlabeled fatty acids, were given by gastric intubation to rats with cannulated thoracic ducts. The chyle or chylomicron lipid so obtained was chromatographed on silicic acid columns to separate cholesterol esters and glycerides (the latter being 98.2% triglycerides). After assaying each lipid class for total radioactivity, gas-liquid chromatography was employed to measure the total mass and the distribution of mass and of radioactivity in the individual fatty acid components of each lipid fraction. The specific radioactivity of each fatty acid in each fraction could then be calculated. The data provided quantitative information on the relative specificity of incorporation of each fatty acid into each chylomicron lipid class and on the relative extent to which each fatty acid in each lipid fraction was diluted with endogenous fatty acid. With the exception of a slight discrimination against stearic acid, the processes of fatty acid absorption and chylomicron triglyceride formation displayed no specificity for one fatty acid relative to another. In contrast, chylomicron cholesterol ester formation showed marked specificity for oleic acid, relative to the other three fatty acids. This specificity was not significantly altered by varying the composition of the test meal, by including cholesterol in the test meal, or by feeding the animal a high-cholesterol diet for several weeks preceding the study. Considerable dilution of the dietary fatty acids with endogenous fatty acids was observed. In one experiment, 43% of the chylomicron triglyceride fatty acids was of endogenous origin. Relatively more (54%) of the cholesterol ester fatty acids was of endogenous origin.
About 100,000 metric tons of the natural fatty acids are consumed in the preparation of various fatty acid esters. The simple esters with lower chain alcohols (methyl-, ethyl-, n-propyl-, isopropyl- and butyl esters) are used as emollients in cosmetics and other personal care products and as lubricants. Esters of fatty acids with more complex alcohols, such as sorbitol, ethylene glycol, diethylene glycol, and polyethylene glycol are consumed in foods, personal care, paper, water treatment, metal working fluids, rolling oils, and synthetic lubricants.
- Kersten S (April 2001). "Mechanisms of nutritional and hormonal regulation of lipogenesis". EMBO Rep. 2 (4): 282–6. doi:10.1093/embo-reports/kve071. PMC 1083868. PMID 11306547. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1083868/.
- Elmhurst College. "Lipogenesis". http://www.elmhurst.edu/~chm/vchembook/623acetylCoAfate.html. Retrieved 2007-12-22.
- J. Pearce (1983). "Fatty acid synthesis in liver and adipose tissue". Proceedings of the Nutrition Society 2: 263-271. doi:10.1079/PNS19830031.
- Work from Howard Towle, Catherine Postic, and K. Uyeda.
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. アルコール性肝疾患の病因 pathogenesis of alcoholic liver disease
- 2. 循環障害における肝障害の病因 pathogenesis of liver injury in circulatory failure
- 3. 成人の2型糖尿病治療におけるメトホルミン metformin in the treatment of adults with type 2 diabetes mellitus
- 4. 非アルコール性脂肪性肝疾患の病因 pathogenesis of nonalcoholic fatty liver disease
- 5. 新生児高血糖 neonatal hyperglycemia
- Tweet Definitions lipogenesis - Medical Definition [lĭpˌə-jĕnˈĭ-sĭs] noun Production of fat, either fatty degeneration or fatty infiltration. Also called adipogenesis. The normal deposition of fat or the conversion of carbohydrate or protein to ...
- lipogenesis lip·o·gen·e·sis (lĭp'ə-jěn'ĭ-sĭs) n. Production of fat, either fatty degeneration or fatty infiltration. Also called adipogenesis. The normal deposition of fat or the conversion of carbohydrate or protein to fat. lip'o·gen'ic (-jěn'ĭk) or ...